Phase 3 trial for inv 102 ?

I wonder if this has any legs?

http://adisinsight.springer.com/trials/700281603

Trial Profile
A phase III study of oral Nadolol (INV102) as a treatment for patients with COPD who cannot quit cigarette smoking.

Planning
Phase of Trial: Phase III
Latest Information Update: 08 Feb 2017

At a glance

• • DrugsNadolol (Primary)
  • IndicationsChronic obstructive pulmonary disease
  • FocusTherapeutic Use

Most Recent Events

• • 08 Feb 2017New trial record

Restricted Access
Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

• Login with a username/password associated to an account with a valid subscription
• Contact your organization’s admin about adding this content to your AdisInsight subscription
• Request a trial

If you are a subscriber to this content then contact us at [email protected] so we can help